# Preventive Application of Letrozole Decrease Incidence of Early Onset of OHSS

> **NCT02670304** · PHASE4 · COMPLETED · sponsor: **First Affiliated Hospital, Sun Yat-Sen University** · enrollment: 100 (actual)

## Conditions studied

- Ovarian Hyperstimulation Syndrome

## Interventions

- **DRUG:** letrozole
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT02670304
- **Lead sponsor:** First Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2013-07
- **Final completion:** 2013-08
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02670304

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02670304, "Preventive Application of Letrozole Decrease Incidence of Early Onset of OHSS". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02670304. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*